Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scinai Immunotherapeutics Ltd ADR JERUSALEM BIOPARK 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 ISR

www.scinai.com Employees: 31 P: 972-8930-2529 F: 972-893-0253

Description:

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is based in JERUSALEM.

Key Statistics

Overview:

Market Capitalization, $K 2,121
Enterprise Value, $K 16,481
Shares Outstanding, K 581
Annual Sales, $ 0 K
Annual Net Income, $ -6,500 K
Last Quarter Sales, $ 280 K
Last Quarter Net Income, $ -2,320 K
EBIT, $ -5,860 K
EBITDA, $ -9,200 K
60-Month Beta 2.46
% of Insider Shareholders 6.03%
% of Institutional Shareholders 58.41%
Float, K 546
% Float 93.97%
Short Volume Ratio 0.27

Growth:

1-Year Return -45.45%
3-Year Return -98.33%
5-Year Return -99.37%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 53.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.57 on 08/15/24
Next Earnings Date 11/05/24 [--]
Earnings Per Share ttm -254.17
EPS Growth vs. Prev Qtr 10.75%
EPS Growth vs. Prev Year 67.84%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/21/24

SCNI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -107.47%
Profit Margin % 0.00%
Debt/Equity -2.72
Price/Sales 6.57
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -15.83
Interest Coverage -0.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar